These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22330158)

  • 21. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer screening.
    Bretthauer M
    J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing risks and benefits of colorectal cancer screening in elderly patients.
    Ko CW; Sonnenberg A
    Gastroenterology; 2005 Oct; 129(4):1163-70. PubMed ID: 16230070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [What is needed for colorectal cancer screening in Japan].
    Saito H; Machii R; Takahashi N; Saika K
    Gan To Kagaku Ryoho; 2012 Jan; 39(1):13-8. PubMed ID: 22241347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colorectal Cancer Screening: Is Colonoscopy the Best Option?
    Liang PS; Dominitz JA
    Med Clin North Am; 2019 Jan; 103(1):111-123. PubMed ID: 30466668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colon cancer screening. Sigmoidoscopy or colonoscopy.
    Khullar SK; DiSario JA
    Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):365-86. PubMed ID: 9177140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current colorectal cancer screening strategies: overview and obstacles to implementation.
    Rex DK
    Rev Gastroenterol Disord; 2002; 2 Suppl 1():S2-11. PubMed ID: 12439393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colorectal cancer: a summary of the evidence for screening and prevention.
    Wilkins T; Reynolds PL
    Am Fam Physician; 2008 Dec; 78(12):1385-92. PubMed ID: 19119558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of various strategies for colorectal cancer screening tests.
    Wohl P; Bednařík M; Wohl P; Cervenka M; Spičák J
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1157-64. PubMed ID: 21989120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colon cancer screening in 2010: an up-date.
    Weizman AV; Nguyen GC
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):181-8. PubMed ID: 20485255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of technology overlapping: a case study on colorectal cancer screening.
    Di Bidino R; Cicchetti A; Corio M; Polisena J; Oradei M; Marchetti M
    Technol Health Care; 2010; 18(4-5):303-15. PubMed ID: 21209479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for colorectal cancer.
    Saliangas K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal occult blood testing.
    Sanford KW; McPherson RA
    Clin Lab Med; 2009 Sep; 29(3):523-41. PubMed ID: 19840685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening for colorectal cancer: recommendations].
    Vonlaufen A; Troillet FX; Armenian B
    Rev Med Suisse; 2013 Apr; 9(381):754-7. PubMed ID: 23659152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Screening for colorectal cancer: what is the most effective strategy?].
    Merzenich H; Giersiepen K; Kieschke J; Zeeb H
    Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.